ARWR

Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)

About Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR)

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Details

Daily high

$69.26

Daily low

$66.06

Price at open

$67.46

52 Week High

$95.49

52 Week Low

$30.70

Market cap

9.4B

Dividend yield

Volume

2.3M

Avg. volume

2.0M

P/E ratio

-29.64

Arrowhead Pharmaceuticals, Inc. - Common Stock News